Medvedev on Sinner’s doping case: “I’m trying to distance myself from the situation. Yannick does what he has to do, just like WADA.”

Russian world number five Daniel Medvedev said he was trying to distance himself from the doping scandal involving Jannik sinner emphasizing that the Italian athlete is struggling to cope with the situation.

Last week, the World Anti-Doping Agency (WADA) announced that it had appealed the decision of the International Tennis Integrity Agency (ITIA) in the case of world number one Sinner to the Court of Arbitration for Sport ( TAS). In August, the ITIA announced that the Italian had passed two positive doping tests in March. He avoided disqualification because he proved that the banned substance, clostebol, entered his body by accident. WADA requires that the athlete be suspended for a period of one to two years.

— What do you think of the Sinner doping affair?

— To be honest, I haven’t really discussed it in the locker room, only with my Russian friends, because we communicate more. In general, as with everything in life, some people think it should be removed, while others think it shouldn’t be.

I try to distance myself from the situation, which is very difficult for him. No one wants to find themselves in this situation, because imagine if tomorrow you received a letter saying that you failed a drug test because of the presence of a drug that you don’t even know the name of in your sample. You’re like, “Wow, what do I do now?” I have no idea how this drug gets into my urine, blood, etc.

Yes, it’s a difficult situation. Yannick does what he has to do, just like WADA. Let’s see how this all ends. We thought everything was over, but no,” Medvedev said at a press conference.

Sinner has topped the Association of Tennis Professionals (ATP) rankings since June. He won 16 tournaments under the auspices of the organization, including two Grand Slam tournaments: the Australian Open and the US Open.

More sports news in our telegram channel .

Source : MatchTV

Related articles

Comments

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share article

Latest articles

Newsletter

Subscribe to stay updated.